Quick Answer
IMAX CORP reported R&D Expense of $5.82 million for fiscal year 2025.
IMAX CORP R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $5.82M | +14.0% |
| 2024 | $5.10M | -49.5% |
| 2023 | $10.11M | +90.8% |
| 2022 | $5.30M | -23.7% |
| 2021 | $6.94M | +23.6% |
| 2020 | $5.62M | +8.0% |
| 2019 | $5.20M | -62.1% |
| 2018 | $13.73M | -34.2% |
| 2017 | $20.86M | +27.8% |
| 2016 | $16.32M | +28.2% |
| 2015 | $12.73M | -20.9% |
| 2014 | $16.10M | +9.0% |
| 2013 | $14.77M | +29.4% |
| 2012 | $11.41M | +45.8% |
| 2011 | $7.83M | +25.3% |
| 2010 | $6.25M | +66.4% |
| 2009 | $3.75M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.50M | — | -2.4% |
| June 30, 2025 | $1.54M | -24.1% | +17.0% |
| March 31, 2025 | $1.32M | -39.7% | -35.1% |
| June 30, 2024 | $2.03M | -26.5% | -7.1% |
| March 31, 2024 | $2.19M | +17.9% | -21.1% |
| September 30, 2023 | $2.77M | +148.5% | +0.3% |
| June 30, 2023 | $2.76M | +103.7% | +48.9% |
| March 31, 2023 | $1.85M | +55.0% | +66.4% |
- IMAX CORP showed an increase of +14.0% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2025 period, IMAX CORP’s r&d expense has grown by 54.9% (from $3.75 million to $5.82 million).
- The most recent figure is from IMAX CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: